From Fighting Shoplifting to Pioneering Gene Therapies, the Startups in This Accelerator Are on the Front Lines of “Super Creativity”

The startups within UF Innovate, as well as the accelerator itself, are vivid examples of what creativity and innovation expert James Taylor, based in Scotland, describes as SuperCreativity—a phenomenon that many business leaders are trying to foster in today’s fast-changing business environment. It is a concept that goes beyond creativity or innovation alone.

UF Innovate Hosts First Fast Break Ventures Summit

Investors, innovators, and entrepreneurs convened at the University of Florida Stephen C. O’Connell Center for UF Innovate | Ventures’ first-annual Fast Break Ventures Summit. Over 100 attendees met on center court for an afternoon filled with discussion on the state of venture capital in Florida and to hear pitches from six startup companies. 

Genascence Announces First Close in Series a Financing Led by Pacira BioSciences and Expands Board of Directors and Scientific Advisory Board

Genascence Corporation (“Genascence”), a clinical-stage biotechnology company revolutionizing the treatment of prevalent musculoskeletal diseases with gene therapy, today announced it has completed the first closing in a Series A financing led by Pacira BioSciences, Inc., totaling $10.5 million. As part of the financing, UF Innovate’s Jackson Streeter, joins Genascence’s board of directors.

Jackson Streeter to Direct UF Innovate | Ventures

In March of 2019, Brammer Bio, a University of Florida spinout company, sold for $1.7 billion to Thermo Fisher Scientific. The story of Brammer is a model of how UF can foster commercialization of research, and UF Innovate | Ventures plans to do just that. “Our hope is that with the new Ventures group and […]